ID24439A - Penggunaan tiazolidindion untuk pengobatan hiperglikemia - Google Patents

Penggunaan tiazolidindion untuk pengobatan hiperglikemia

Info

Publication number
ID24439A
ID24439A IDW20000670A ID20000670A ID24439A ID 24439 A ID24439 A ID 24439A ID W20000670 A IDW20000670 A ID W20000670A ID 20000670 A ID20000670 A ID 20000670A ID 24439 A ID24439 A ID 24439A
Authority
ID
Indonesia
Prior art keywords
tiazolidindion
hyperglicemia
treatment
hyperglicemia treatment
Prior art date
Application number
IDW20000670A
Other languages
English (en)
Indonesian (id)
Inventor
Robin E Buckingham
Stephen A Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID24439A publication Critical patent/ID24439A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20000670A 1997-10-13 1998-10-12 Penggunaan tiazolidindion untuk pengobatan hiperglikemia ID24439A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721692.3A GB9721692D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
ID24439A true ID24439A (id) 2000-07-20

Family

ID=10820481

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000670A ID24439A (id) 1997-10-13 1998-10-12 Penggunaan tiazolidindion untuk pengobatan hiperglikemia

Country Status (24)

Country Link
EP (1) EP1023057A1 (tr)
JP (1) JP2001519383A (tr)
KR (1) KR20010024482A (tr)
CN (1) CN1281358A (tr)
AP (1) AP1223A (tr)
AU (1) AU9547198A (tr)
BG (1) BG104405A (tr)
BR (1) BR9815220A (tr)
CA (1) CA2305289A1 (tr)
CZ (1) CZ20001298A3 (tr)
EA (1) EA200000418A1 (tr)
GB (1) GB9721692D0 (tr)
HR (1) HRP20000256A2 (tr)
HU (1) HUP0003673A3 (tr)
ID (1) ID24439A (tr)
IL (1) IL135515A0 (tr)
NO (1) NO20001897L (tr)
OA (1) OA11519A (tr)
PL (1) PL339804A1 (tr)
SK (1) SK5322000A3 (tr)
TR (1) TR200000957T2 (tr)
UA (1) UA66809C2 (tr)
WO (1) WO1999018944A1 (tr)
YU (1) YU28700A (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140664A0 (en) * 1998-07-21 2002-02-10 Smithkline Beecham Plc Use of glucose uptake enhancer for reducing apoptosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
SK5322000A3 (en) 2000-09-12
CZ20001298A3 (cs) 2001-08-15
GB9721692D0 (en) 1997-12-10
UA66809C2 (uk) 2004-06-15
IL135515A0 (en) 2001-05-20
WO1999018944A1 (en) 1999-04-22
OA11519A (en) 2004-02-09
HUP0003673A3 (en) 2001-12-28
TR200000957T2 (tr) 2000-08-21
CN1281358A (zh) 2001-01-24
CA2305289A1 (en) 1999-04-22
AP2000001788A0 (en) 2000-06-30
YU28700A (sh) 2003-10-31
BG104405A (en) 2000-12-29
KR20010024482A (ko) 2001-03-26
EP1023057A1 (en) 2000-08-02
NO20001897L (no) 2000-06-09
PL339804A1 (en) 2001-01-02
HRP20000256A2 (en) 2000-12-31
HUP0003673A2 (hu) 2001-10-28
NO20001897D0 (no) 2000-04-12
AP1223A (en) 2003-11-13
JP2001519383A (ja) 2001-10-23
EA200000418A1 (ru) 2000-10-30
BR9815220A (pt) 2000-11-14
AU9547198A (en) 1999-05-03

Similar Documents

Publication Publication Date Title
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
NO983266D0 (no) Distribuert Behandling
DK0951447T3 (da) Vandbehandling
NO992806L (no) Terapeutiske midler
DE69524138T2 (de) Hautbehandlungsmittel
ID18679A (id) Penggunaan terapi lanjutan
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
DE69807225D1 (de) Vliesstoffbehandlung
DE69833493D1 (de) Gewebe
ID21948A (id) Penggunaan 1-hidroksi-2piridon untuk pengobatan infeksi-infeksi kulit
NO983263D0 (no) Distribuert behandling
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
IS4789A (is) Meðferðarefnasambönd
ID24270A (id) Penghilang sumbatan keratotik
ID23437A (id) Penghilang sumbatan keratotik
ID24922A (id) Terapi kombinasi untuk pengobatan aids
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69812879D1 (de) Patientenliege
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID17383A (id) Penggunaan terbaru turunan turunan sistina
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
FI974508A (fi) Iskuja synnyttävä laite
NO20000274D0 (no) Behandling av fluider
ID29414A (id) Pengobatan depresi
ID17459A (id) Unsur-unsur pengobatan